Biological effectiveness of antiproton annihilation

被引：19

作者：

Holzscheiter, MH

Agazaryan, N

Bassler, N

Beyer, G

DeMarco, JJ

Doser, M

Ichioka, T

Iwamoto, KS

Knudsen, HV

Landua, R

Maggiore, C

McBride, WH

Moller, SP

Petersen, J

Smathers, JB

Skarsgard, LD

Solberg, TD

Uggerhoj, UI

Withers, HR

Vranjes, S

Wong, M

Wouters, BG

机构：

[1] PBar Labs, Newport Beach, CA 92660 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark

[4] Ctr Med Univ Geneva, CH-1211 Geneva 4, Switzerland

[5] CERN, Div EP, CH-1211 Geneva, Switzerland

[6] Aarhus Kommune Hosp, DK-8000 Aarhus, Denmark

[7] British Columbia Canc Res Ctr, Vancouver, BC V5Z 4E6, Canada

[8] Vinca Inst Nucl Sci, YU-11001 Belgrade, Serbia

[9] Univ Maastricht, Res Inst Growth & Dev, Maastricht, Netherlands

来源：

NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS | 2004年 / 221卷

关键词：

antiproton annihilation; Bragg peak; biological response;

D O I：

10.1016/j.nimb.2004.03.057

中图分类号：

TH7 [仪器、仪表];

学科分类号：

0804 ; 080401 ; 081102 ;

摘要：

We describe an experiment designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in "biological dose" in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct measurement of the biological effects of antiproton annihilation. The experiment has been approved by the CERN Research Board for running at the CERN Antiproton Decelerator (AD) as AD-4/ACE (Antiproton Cell Experiment) and has begun data taking in June of 2003. The background, description and the current status of the experiment are given. (C) 2004 Elsevier B.V. All rights reserved.

引用

页码：210 / 214

页数：5

共 9 条

[1]

*CERN, 2002, CERNSPSC2002030

[2] POSSIBLE BIOMEDICAL APPLICATIONS OF ANTIPROTON BEAMS - FOCUSED RADIATION TRANSFER [J].

GRAY, L ;

KALOGEROPOULOS, TE .

RADIATION RESEARCH, 1984, 97 (02) :246-252

[3] Biological effectiveness of antiproton annihilation [J].

Maggiore, C ;

Agazaryan, N ;

Bassler, N ;

Blackmore, E ;

Beyer, G ;

DeMarco, JJ ;

Doser, M ;

Gruhn, CR ;

Holzscheiter, MH ;

Ichioka, T ;

Iwamoto, KS ;

Knudsen, HV ;

Landua, R ;

McBride, WH ;

Moller, SP ;

Petersen, J ;

Smathers, JB ;

Skarsgard, LD ;

Solberg, TD ;

Uggerhoj, UI ;

Withers, HR ;

Wouters, BG .

NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS, 2004, 214 :181-185

[4]

MAKOTO C, 2000, AT0001 CERN AD

[5] RADIOBIOLOGY OF PIONS AT TRIUMF [J].

SKARSGARD, LD ;

PALCIC, B ;

DOUGLAS, BG ;

LAM, GKY .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (12) :2127-2132

[6]

*SPSC CERN, 2002, CERNSPSC2002040

[7] A MEASUREMENT OF THE LOCAL ENERGY DEPOSITION BY ANTIPROTONS COMING TO REST IN TISSUE LIKE MATERIAL [J].

SULLIVAN, AH .

PHYSICS IN MEDICINE AND BIOLOGY, 1985, 30 (12) :1297-1303

[8]

Waters L.S., 2002, LACP02408

[9] Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay [J].

Wouters, BG ;

Lam, GKY ;

Oelfke, U ;

Gardey, K ;

Durand, RE ;

Skarsgard, LD .

RADIATION RESEARCH, 1996, 146 (02) :159-170

← 1 →